NEW DELHI : India on Tuesday opened an anti-dumping investigation into ethyl chloroformate imports from China after a domestic producer alleged the chemical used in pharmaceutical and agrochemical manufacturing was being sold at unfairly low prices
The Directorate General of Trade Remedies (DGTR), under the federal trade ministry, said it initiated the probe following an application by Paushak (PAUS.NS), opens new tab that alleged that imports from China had caused “material injury” to domestic producers.
In its filing, Paushak said it is India’s sole domestic producer of ethyl chloroformate and it is responsible for the country’s entire output. It alleged that rising imports from China had led to price suppression and weakened profitability. The DGTR said its preliminary assessment indicated the dumping margin appeared to be above the de minimis level, suggesting significant price undercutting by Chinese exporters.
The investigation will cover the period from October 2024 to September 2025, the DGTR said, and will assess evidence from exporters, importers and other interested parties before deciding whether to recommend duties to the government.
In a separate case, the DGTR also initiated an anti-dumping investigation into imports of hexamine – another intermediate used by the chemical and pharmaceutical industries – originating in or exported from China, Russia and the United Arab Emirates.
Source : Reuters
